Serum osteoprotegerin levels are associated with inflammation and pulse wave velocity
- 26 October 2005
- journal article
- Published by Wiley in Clinical Endocrinology
- Vol. 63 (5) , 594-598
Abstract
Objective We examined the association between serum osteoprotegerin (OPG) levels, systemic inflammation and arterial stiffness in normal and diabetic patients. Patients and measurements The study subjects comprised 49 newly diagnosed diabetic patients and 72 age‐ and sex‐matched normal glucose controls. Anthropometric parameters, blood pressure, fasting blood glucose (FBG), lipid profiles, serum OPG, high‐sensitive C‐reactive protein (hsCRP), interleukin‐6 (IL‐6) and brachial‐ankle pulse wave velocity (baPWV) were measured. Results Serum OPG levels (6·1 ± 1·4 vs. 5·4 ± 1·3 pmol/l, P = 0·011) and baPWV (1562 ± 354 vs. 1399 ± 257 cm/s, P = 0·004) were significantly higher in the diabetic group than in the normal glucose group. Serum OPG levels in normal and diabetic patients correlated significantly with systolic blood pressure (r = 0·20, P = 0·035), FBG (r = 0·30, P = 0·002), right baPWV (r = 0·22, P = 0·021), left baPWV (r = 0·26, P = 0·006), homeostasis model assessment insulin resistance (HOMA‐IR) (r = 0·19, P = 0·045), IL‐6 (r = 0·32, P = 0·001) and hsCRP (r = 0·21, P = 0·027) after adjusting for age and sex. Multiple regression analysis showed that serum OPG level was significantly associated with age, FBG, IL‐6, systolic blood pressure, triglyceride and hsCRP (R2 = 0·299). Conclusions In summary, serum OPG and baPWV levels are elevated in diabetic patients and serum OPG levels are significantly associated with inflammation and arterial stiffness.Keywords
This publication has 31 references indexed in Scilit:
- Osteoprotegerin and Diabetic MacroangiopathyHormone and Metabolic Research, 2005
- Relationship of serum osteoprotegerin levels with coronary artery disease severity, left ventricular hypertrophy and C-reactive proteinClinical Science, 2005
- Diagnosis and Classification of Diabetes MellitusDiabetes Care, 2005
- Regulation of Vascular Calcification by Osteoclast Regulatory Factors RANKL and OsteoprotegerinCirculation Research, 2004
- Prognostic value of osteoprotegerin in heart failure after acute myocardial infarctionJACC, 2004
- Inflammation in Atherosclerosis and Implications for TherapyCirculation, 2004
- Osteoprotegerin Is a Risk Factor for Progressive Atherosclerosis and Cardiovascular DiseaseCirculation, 2004
- Series of Monographs on Venous Thromboembolic DiseaseCirculation, 2004
- RANK Ligand and OsteoprotegerinArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?Atherosclerosis, 2000